drugset / Trial / NCT00220298

Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism

NCT00220298

Phase 3 Completed 96 enrolled Bayer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will evaluate the preparation of testosterone undecanoate under conditions which resemble real-life situations.

Timeline

Start
2003-02
Primary completion
2007-10
Completion
2007-10

Publications

  • Results Behre HM and Elliesen J. Safety and efficacy of intramuscular injections of 1000 mg testosterone undecanoate: A prospective multicenter study in hypogonadal men under conditions resembling real-life situations. Proceedings of the 22nd Annual European Association of Urology (EAU); 2007 Mar 22; Berlin, Germany. Eur Urol Suppl 2007;6(2):108.

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 1000 mg Intramuscular

Indications